Published in Women's Health Weekly, January 9th, 2003
MMP-3 is an enzyme that breaks down the proteins that hold cells adjacent to one another. The breakdown of these extracellular proteins fosters tumor neovascularization, tumor invasion, and tumor metastasis. Researchers in Milan, Italy think an adenine insertion/deletion polymorphism (5A/6A) on the MMP-3 promoter might advance breast cancer invasion and metastasis in some women.
Study leaders from the Universita degli Studi di Milano, in collaboration with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.